Methylnaltrexone (Relistor) is a peripherally-acting μ-opioid antagonist used for the treatment of opioid induced constipation.

Two independent organizations have recently published updated clinical information on this drug:

The Scottish Medicines Consortium also reviewed Relistor in January 2009.

Are you a visual learner interested in learning psychopharmacology? Click here to get our videos